nystatin-a1 and Endocarditis--Bacterial

nystatin-a1 has been researched along with Endocarditis--Bacterial* in 2 studies

Other Studies

2 other study(ies) available for nystatin-a1 and Endocarditis--Bacterial

Article	Year
Fungal endocarditis complicating treatment of prosthetic valve bacterial endocarditis: value of prophylactic oral nystatin. Southern medical journal, 1987, Volume: 80, Issue:11 We describe two patients in whom fungal endocarditis occurred during antibiotic therapy for prosthetic valve bacterial endocarditis. Successful management of both patients was eventually achieved with antifungal therapy and replacement of the prosthetic valves. These cases and review of the literature suggest that (1) high-dose antibacterial therapy predisposes to fungal endocarditis; (2) during prolonged antibiotic therapy in patients predisposed to endocarditis, clinicians should consider the use of oral nystatin as prophylaxis against fungemia and possible fungal endocarditis; and (3) early replacement of prosthetic valves infected with fungi is indicated because chemotherapy alone is predictably inadequate to effect a cure. Topics: Adult; Anti-Bacterial Agents; Candidiasis; Endocarditis; Endocarditis, Bacterial; Female; Heart Valve Prosthesis; Humans; Male; Middle Aged; Nystatin	1987
Systemic candidiasis (moniliasis) complicating treatment of bacterial endocarditis, with review of literature and report of apparent cure of one case with parenteral mycostatin. Annals of internal medicine, 1958, Volume: 49, Issue:1 Topics: Anti-Bacterial Agents; Bacteremia; Candidiasis; Endocarditis, Bacterial; Humans; Nystatin; Sepsis	1958

Article

Year

Fungal endocarditis complicating treatment of prosthetic valve bacterial endocarditis: value of prophylactic oral nystatin.

Southern medical journal, 1987, Volume: 80, Issue:11

We describe two patients in whom fungal endocarditis occurred during antibiotic therapy for prosthetic valve bacterial endocarditis. Successful management of both patients was eventually achieved with antifungal therapy and replacement of the prosthetic valves. These cases and review of the literature suggest that (1) high-dose antibacterial therapy predisposes to fungal endocarditis; (2) during prolonged antibiotic therapy in patients predisposed to endocarditis, clinicians should consider the use of oral nystatin as prophylaxis against fungemia and possible fungal endocarditis; and (3) early replacement of prosthetic valves infected with fungi is indicated because chemotherapy alone is predictably inadequate to effect a cure.

Topics: Adult; Anti-Bacterial Agents; Candidiasis; Endocarditis; Endocarditis, Bacterial; Female; Heart Valve Prosthesis; Humans; Male; Middle Aged; Nystatin

1987

Systemic candidiasis (moniliasis) complicating treatment of bacterial endocarditis, with review of literature and report of apparent cure of one case with parenteral mycostatin.

Annals of internal medicine, 1958, Volume: 49, Issue:1

Topics: Anti-Bacterial Agents; Bacteremia; Candidiasis; Endocarditis, Bacterial; Humans; Nystatin; Sepsis

1958